Xontaz 1.125g Injection
Marketer
Adjener Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Xontaz 1.125g Injection
Xontaz 1.125g Injection, a multifaceted antibacterial formulation, combats diverse bacterial infections by hindering microbial proliferation and propagation. Administration must be overseen by a healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial; prematurely halting treatment compromises its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and digestive upset. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all current medications prior to commencing treatment. Pregnant or lactating individuals require medical guidance before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness mandates driving cessation. Adequate rest, balanced nutrition, and ample hydration promote faster recovery. Monitoring treatment efficacy may involve periodic laboratory and diagnostic testing.
Uses of Xontaz 1.125g Injection
Infections caused by bacteria
Major Benefits of Xontaz 1.125g Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Xontaz 1.125g Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Xontaz 1.125g Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Xontaz 1.125g Injection works:
Ceftriaxone and Tazobactum, combined as Xontaz 1.125g Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The inclusion of Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Xontaz 1.125g Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Xontaz 1.125g Injection is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or absent negative consequences for fetal development; nevertheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
Administering Xontaz 1.125g Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Xontaz 1.125g Injection may induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xontaz 1.125g Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when administering Xontaz 1.125g Injection, as dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Xontaz 1.125g Injection is generally unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Xontaz 1.125g Injection :
Should you omit a scheduled dose of Xontaz 1.125g Injection, seek medical advice.
Facts to Know About Xontaz 1.125g Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Antimicrobial Agents |
3,018 People bought this recently